for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Beigene's cancer therapy trial meets main goal

May 21 (Reuters) - China-based biotech firm Beigene Ltd , said on Friday a late-stage study testing its cancer therapy, tislelizumab, in combination with chemotherapy to treat metastatic nasopharyngeal cancer met the main goal. (refini.tv/3ypTB6G) (Reporting by Trisha Roy in Bengaluru; Editing by Ramakrishnan M.)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up